Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Financials
Key financial figures for Madrigal Pharmaceuticals, Inc. Common Stock (Q1 2026).
- Revenue
- $311M
- Net Income
- -$94M
- EPS
- $-3.25
- Total Assets
- $1.2B
- Operating Cash Flow
- -$167M
Full income statement, balance sheet, and cash flow for Madrigal Pharmaceuticals, Inc. Common Stock on SentiSense.